GSK bets on chimp virus with $321 million vaccines buy
LONDON (Reuters) - GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by acquiring Swiss-based Okairos for 250 million...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/NfgxvGZ5bMI/story01.htm
No comments:
Post a Comment